References
- Division of STD Prevention. Sexually transmitted disease surveillance, 1996. Atlanta: US Dept of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, 1997 Sept
- Hook EW, Zenilman JM. Gonorrhea. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious diseases. 2d ed. Philadelphia: Saunders, 1998: 969–74
- Fox KK, Whittington WL, Levine WC, et al. Gonorrhea in the United States, 1981–1996: demographic and geographic trends. Sex Transm Dis 1998; 25(7)386–93
- Handsfield HH, Sparling PF. Neisseria gonorrhoeae. In: Mandell GL, Douglas RG, Bennett JE, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995: 1909–26
- Ellen JM, Hessol NA, Kohn, RP, et al. An investigation of geographic clustering of repeat cases of gonorrhea and chlamydial infection in San Francisco, 1989–199): evidence for core groups. J Infect Dis 1997; 175(6): 1519–22
- Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998; 47(RR-1): 1–118
- Goodhart ME, Ogden J, Zaidi AA, et al. Factors affecting the performance of smear and culture tests for the detection of Neisseria gonorrhoeae. Sex Transm Dis 1982; 9(2): 6)-9
- Koumans EH, Johnson RE, Knapp JS, et al. Laboratory testing for Neisseria gonorrhoea by recently introduced nonculture tests: a performance review with clinical and public health considerations. Clin Infect Dis 1998; 27: 1171–80
- Young H, Anderson J, Moyes A, et al. Non-cultural detection of rectal and pharyngeal gonorrhea by the Gen-Probe PACE 2 assay. Genitourin Med 1997; 73(1): 59–62
- Ciemins EL, Borenstein LA, Dyer IE, et al. Comparisons of cost and accuracy of DNA probe test and culture for the detection of Neisseria gonorrhoeae in patients attending public sexually transmitted disease clinics in Los Angeles County. Sex Transm Dis 1997; 24(7): 422–8
- Lind I. Antimicrobial resistance in Neisseria gonorrhoeae. Clin Infect Dis 1997; 24(Suppl 1): S93–7
- Ison CA, Dillon JR, Tapsall JW. The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi. Lancet 1998; 351(Suppl III): 8–11
- Carne CA. Epidemiological treatment and tests of cure in gonococcal infection: evidence for value. Genitourin Med 1997; 7)(1): 12–5
- Brodine SK, Shafer MA, Shaffer RA, et al. Asymptomatic sexually transmitted disease prevalence in tour military populations: application of DNA amplification assays for Chlamydia and gonorrhea screening. J Infect Dis 1998; 178(4): 1202–4
- Roddy RE, Cordero M, Ryan KA, et al. A randomized controlled trial coin- paring nonoxynol-9 lubricated condoms with silicone lubricated condoms for prophylaxis. Sex Transm Dis 1998: 74(2): 116–9
- Centers for Disease Control and Prevention. Summary of notifiable diseases. United States, 1997. MMWR Morb Mortal Wkly Rep 1998; 46(54): 73
- Hook EW 3d. Acquired syphilis in adults. N Engl J Med 1992; 326(16): 1060–9
- Adimora AA. Syphilis and other tre ponematoses. In: Kassirer JP, Greene HL, eds. Current therapy in adult medicine. 4th ed. St Louis: Mosby, 1997: 289–92
- Musher DM. Early syphilis. In: Holmes KK, ed. Sexually transmitted diseases. 3d ed. New York: McGraw-Hill, 1999: 479–85
- Larkin JA, Lit L, Toney J, et al. Recognizing and treating syphilis in pregnancy. Infect Med 1998; 15: 199–203
- Hook EW 3d, Roddy RE, Handsfield HH. Ceftriaxone therapy tor incubating and early syphilis. J Infect Dis 1988; 158(4): 881–4
- Romanowski B, Sutherland R, Fick GH, et al. Serologic response to treatment of infectious syphilis. Ann Intern Med 1991; 114: 1005–9